We found that doses of tetracenomycin X elevated the phosphorylation levels of the p38 and c-JUN proteins in the five lung cancer cells, and tetracenomycin X (5 μmol/L) also active the p38 and c-JUN proteins in 4–16 h in the A549 and H460 cells. Here, JUN is linked to lung carcinoma.